{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:54:53Z","timestamp":1791248093498,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft (DFG)","award":["TRR77"],"award-info":[{"award-number":["TRR77"]}]},{"name":"Deutsche Forschungsgemeinschaft (DFG)","award":["SFB621"],"award-info":[{"award-number":["SFB621"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.bpg.2011.08.003","type":"journal-article","created":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T16:24:47Z","timestamp":1322670287000},"page":"673-687","source":"Crossref","is-referenced-by-count":38,"title":["Therapy of autoimmune hepatitis"],"prefix":"10.1016","volume":"25","author":[{"given":"Christian P.","family":"Strassburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2011.08.003_bib1","first-page":"113","article-title":"Blutproteine und Nahrungseiweisse","volume":"15","author":"Leber","year":"1950","journal-title":"Dtsch Gesellsch Verd Stoffw"},{"key":"10.1016\/j.bpg.2011.08.003_bib2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(56)91483-0","article-title":"Lupoid hepatitis","volume":"2","author":"Mackay","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2011.08.003_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1385\/CRIAI:18:2:127","article-title":"Autoimmunity in liver diseases","volume":"18","author":"Strassburg","year":"2000","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.bpg.2011.08.003_bib4","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.08.003_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2002-35704","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis","volume":"22","author":"Strassburg","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2011.08.003_bib7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jhep.2006.07.008","article-title":"Autoimmune hepatitis in the elderly: what is the difference?","volume":"45","author":"Strassburg","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.08.003_bib9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0676.1995.tb00676.x","article-title":"Autoimmune hepatitis versus viral hepatitis C","volume":"15","author":"Strassburg","year":"1995","journal-title":"Liver"},{"key":"10.1016\/j.bpg.2011.08.003_bib11","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpg.2011.08.003_bib12","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal antibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpg.2011.08.003_bib13","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0016-5085(96)70020-3","article-title":"Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis","volume":"111","author":"Strassburg","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.08.003_bib14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2011.08.003_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840180102","article-title":"Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis","volume":"18","author":"Stechemesser","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib16","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","article-title":"Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion","volume":"89","author":"Gelpi","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpg.2011.08.003_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/jhep.2001.22218","article-title":"Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis","volume":"33","author":"Volkmann","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib18","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis [see comments]","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2011.08.003_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2009.07.005","article-title":"SLA\/LP\/tRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract","volume":"34","author":"Volkmann","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.bpg.2011.08.003_bib20","first-page":"327","article-title":"Histologic features in autoimmune hepatitis","volume":"27","author":"Dienes","year":"1989","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.bpg.2011.08.003_bib21","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0168-8278(97)80107-9","article-title":"Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatiis C","volume":"26","author":"Nishioka","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.08.003_bib22","series-title":"Geographical variation in the frequency and characteristics of autoimmune liver diseases","author":"Nishioka","year":"1998"},{"key":"10.1016\/j.bpg.2011.08.003_bib23","series-title":"Autoimmune hepatitis in South America","author":"Cancado","year":"2000"},{"key":"10.1016\/j.bpg.2011.08.003_bib24","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1136\/gut.21.1.78","article-title":"Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis","volume":"21","author":"Kirk","year":"1980","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.08.003_bib25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0016-5085(19)33990-3","article-title":"Classification and treatment of chronic active liver disease","volume":"55","author":"Geall","year":"1968","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.08.003_bib26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.08.003_bib27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib28","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with anti liver\/kidney microsome type 1: a second type of \"autoimmune\" hepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib29","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","article-title":"Autoimmune hepatitis: clinical challenges","volume":"120","author":"Manns","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.08.003_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","article-title":"Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis","volume":"139","author":"Czaja","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.08.003_bib31","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib32","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for long-term maintenance of remission in autoimmune hepatitis","volume":"333","author":"Johnson","year":"1995","journal-title":"N Engl.J Med"},{"key":"10.1016\/j.bpg.2011.08.003_bib33","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0168-8278(94)80251-3","article-title":"The nature and prognostic implications of autoimmune hepatitis with acute presentation","volume":"21","author":"Nikias","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.08.003_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ageing\/26.6.441","article-title":"Autoimmune hepatitis in older patients","volume":"26","author":"Newton","year":"1997","journal-title":"Age Ageing"},{"key":"10.1016\/j.bpg.2011.08.003_bib35","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1572-0241.2001.03782.x","article-title":"Autoimmune hepatitis in the elderly","volume":"96","author":"Schramm","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.08.003_bib36","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","author":"Czaja","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib37","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.08.003_bib38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","article-title":"Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre","volume":"45","author":"Al-Chalabi","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.08.003_bib39","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.autrev.2005.09.008","article-title":"Aging of the immune system: a risk factor for autoimmunity?","volume":"5","author":"Prelog","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bpg.2011.08.003_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08916939108997112","article-title":"Hypothesis: the aging paradox and autoimmune disease","volume":"8","author":"Talor","year":"1991","journal-title":"Autoimmunity"},{"key":"10.1016\/j.bpg.2011.08.003_bib41","first-page":"1687","article-title":"Synthesis and anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity","volume":"29","author":"Thalen","year":"1979","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.bpg.2011.08.003_bib42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2036.1994.tb00334.x","article-title":"Oral budesonide for treatment of autoimmune chronic hepatitis","volume":"8","author":"Danielson","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2011.08.003_bib43","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/gast.2000.0010000001","article-title":"Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis","volume":"119","author":"Czaja","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.08.003_bib44","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1478-3231.2005.01122.x","article-title":"Budesonide in previously untreated autoimmune hepatitis","volume":"25","author":"Wiegand","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2011.08.003_bib45","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.08.003_bib46","first-page":"630","article-title":"Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis","volume":"91","author":"Rebollo Bernardez","year":"1999","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.bpg.2011.08.003_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00104-007-1456-8","article-title":"Progress in immunosuppression","volume":"79","author":"Strassburg","year":"2008","journal-title":"Chirurg"},{"key":"10.1016\/j.bpg.2011.08.003_bib48","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(99)80065-8","article-title":"Short-term cyclosporine induces a remission of autoimmune hepatitis in children","volume":"30","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.08.003_bib49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3476(99)70339-2","article-title":"Efficacy of cyclosporin A in children with type 2 autoimmune hepatits","volume":"135","author":"Debray","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.bpg.2011.08.003_bib50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.1999.00807.x","article-title":"Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis","volume":"94","author":"Fernandez","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.08.003_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/jhep.2002.30991","article-title":"Current and novel immunosuppressive therapy for autoimmune hepatitis","volume":"35","author":"Heneghan","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib52","first-page":"771","article-title":"Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.08.003_bib53","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.mcg.0000139050.67178.be","article-title":"Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis","volume":"38","author":"Aqel","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2011.08.003_bib54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(00)80271-8","article-title":"Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine","volume":"33","author":"Richardson","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.08.003_bib55","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.08.003_bib56","first-page":"571","article-title":"Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis - report of three cases","volume":"35","author":"Kanzler","year":"1996","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.bpg.2011.08.003_bib57","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2169\/internalmedicine.50.4879","article-title":"Improvement of rheumatoid arthritis and autoimmune hepatitis in a patient treated with the tumor necrosis factor inhibitor, etanercept","volume":"50","author":"Umekita","year":"2011","journal-title":"Intern Med"},{"issue":"115","key":"10.1016\/j.bpg.2011.08.003_bib58","first-page":"116","article-title":"Anti TNF-alpha therapy can be a novel treatment option in patients with autoimmune hepatitis","volume":"32","author":"Efe","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2011.08.003_bib59","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.berh.2008.09.008","article-title":"Autoimmune diseases induced by TNF-targeted therapies","volume":"22","author":"Ramos-Casals","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.bpg.2011.08.003_bib60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.1840110104","article-title":"Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"11","author":"Calmus","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib61","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.510300603","article-title":"Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial","volume":"30","author":"Czaja","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib62","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1440-1746.1998.tb00674.x","article-title":"Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis [see comments]","volume":"13","author":"Nakamura","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"issue":"95","key":"10.1016\/j.bpg.2011.08.003_bib63","first-page":"1363","article-title":"[Autoimmune liver diseases and their overlap syndromes]","volume":"2006","author":"Strassburg","year":"1994","journal-title":"Praxis (Bern"},{"key":"10.1016\/j.bpg.2011.08.003_bib64","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.08.003_bib65","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3748\/wjg.14.3368","article-title":"Overlap syndromes among autoimmune liver diseases","volume":"14","author":"Rust","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.08.003_bib66","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.1840180103","article-title":"Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis","volume":"18","author":"Ben-Ari","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib67","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1111\/j.1572-0241.2001.04675.x","article-title":"Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis","volume":"96","author":"Angulo","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.08.003_bib68","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/0016-5085(94)90829-X","article-title":"Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?","volume":"107","author":"Colombato","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.08.003_bib69","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib70","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/BF02064201","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A","volume":"40","author":"Duclos-Vallee","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.08.003_bib71","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2011.08.003_bib72","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.08.003_bib73","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1478-3231.2007.01538.x","article-title":"Development of autoimmune hepatitis in primary biliary cirrhosis","volume":"27","author":"Gossard","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2011.08.003_bib74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.21229","article-title":"Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis","volume":"44","author":"Poupon","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib75","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/gut.35.2.260","article-title":"Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis","volume":"35","author":"Michieletti","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.08.003_bib76","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2006-927280","article-title":"Steroid treatment for severe acute cryptogenic hepatitis","volume":"45","author":"Potthoff","year":"2007","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.bpg.2011.08.003_bib78","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"44","author":"Chazouilleres","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.08.003_bib79","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00108-004-1295-3","article-title":"Liver transplantation: deciding between need and donor allocation","volume":"45","author":"Strassburg","year":"2004","journal-title":"Internist (Berl)"},{"key":"10.1016\/j.bpg.2011.08.003_bib80","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0041-1345(96)00223-0","article-title":"Liver transplantation for autoimmune hepatitis: a 12-year experience","volume":"29","author":"Ahmed","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bpg.2011.08.003_bib81","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00007890-198404000-00009","article-title":"Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting","volume":"37","author":"Neuberger","year":"1984","journal-title":"Transplantation"},{"key":"10.1016\/j.bpg.2011.08.003_bib82","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.bpg.2011.08.003_bib83","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hep.1840150208","article-title":"Prognostic features and role of liver transplantation in severe corticoid-treated autoimmune chronic active hepatitis","volume":"15","author":"Sanchez-Urdazpal","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib84","first-page":"3053","article-title":"Liver transplantation in autoimmune liver disease\u2013selection of patients","volume":"46","author":"Tillmann","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.bpg.2011.08.003_bib85","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2004.00117.x","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis","volume":"18","author":"Vogel","year":"2004","journal-title":"Clin Transpl"},{"key":"10.1016\/j.bpg.2011.08.003_bib86","article-title":"Liver transplantation: indications and results","author":"Strassburg","year":"2009","journal-title":"Internist (Berl)"},{"key":"10.1016\/j.bpg.2011.08.003_bib87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease","volume":"30","author":"Ratziu","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.08.003_bib88","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1432-2277.2008.00729.x","article-title":"Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far?","volume":"22","author":"Schreuder","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.bpg.2011.08.003_bib89","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/lt.500010305","article-title":"Recurrence of autoimmune hepatitis following liver transplantation","volume":"1","author":"Devlin","year":"1995","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.bpg.2011.08.003_bib90","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/jhep.2000.19149","article-title":"Recurrent autoimmune hepatitis after liver transplantation - when non-self becomes self","volume":"32","author":"Manns","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib91","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bpg.2011.08.003_bib92","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00007890-199201000-00027","article-title":"Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease","volume":"53","author":"Wright","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.bpg.2011.08.003_bib93","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0041-1345(98)01692-3","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"31","author":"G\u00f6tz","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bpg.2011.08.003_bib94","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2011.08.003_bib95","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.bpg.2011.08.003_bib96","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2011.08.003_bib97","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2011.08.003_bib98","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation","volume":"35","author":"Salcedo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.08.003_bib99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.510300103","article-title":"Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis","volume":"30","author":"Jones","year":"1999","journal-title":"Hepatology"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691811000849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691811000849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T04:10:13Z","timestamp":1561003813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691811000849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1521691811000849"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2011.08.003","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}